(Q3)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q1)Mar 31, 2023 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q1)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||
Cash flow from continuing operating activities | -52.31K | -380.79K | 66.84%-690.07K | 0 | 0 | 0 | -2.08M | 0 |
Net income from continuing operations | -472.10%-35.71K | -2,228.00%-288.58K | 49.31%-1.41M | 31.92%-8.44K | ---6.24K | ---15.25K | ---2.79M | ---12.4K |
Operating gains losses | --3.58K | ---84.19K | -371.82%-348.51K | ---- | ---- | ---- | ---73.86K | ---- |
Depreciation and amortization | ---- | --6.41K | 56.97%28.43K | ---- | ---- | ---- | --18.11K | ---- |
Asset impairment expenditure | ---- | --27.5K | 113.02%33.56K | ---- | ---- | ---- | --15.75K | ---- |
Remuneration paid in stock | ---- | --59.54K | --281.93K | ---- | ---- | ---- | --0 | ---- |
Other non cashItems | --376.1741 | ---56.08K | -83.61%124.41K | ---- | ---- | ---- | --759.03K | ---- |
Change In working capital | -429.44%-20.56K | -466.19%-45.39K | 4,464.15%602.73K | -31.92%8.44K | --6.24K | --15.25K | ---13.81K | --12.4K |
-Change in receivables | -3,629.77%-2.81K | ---53.69K | 8.28%-40.48K | ---80.5855 | ---75.446 | ---541.7026 | ---44.13K | --0 |
-Change in payables and accrued expense | -380.96%-17.75K | -33.06%8.3K | 2,021.40%643.21K | -31.27%8.52K | --6.32K | --15.79K | --30.32K | --12.4K |
Cash from discontinued investing activities | ||||||||
Operating cash flow | ---52.31K | ---380.79K | 66.84%-690.07K | --0 | --0 | --0 | ---2.08M | --0 |
Investing cash flow | ||||||||
Cash flow from continuing investing activities | 0 | 609.87K | ||||||
Net PPE purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---51.29K | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | --661.16K | ---- |
Cash from discontinued investing activities | ||||||||
Investing cash flow | ---- | ---- | --0 | ---- | ---- | ---- | --609.87K | ---- |
Financing cash flow | ||||||||
Cash flow from continuing financing activities | 31.88K | 439.23K | -56.05%664.69K | 0 | 1.51M | |||
Net issuance payments of debt | ---- | ---- | -100.11%-1.5K | ---- | ---- | ---- | --1.41M | ---- |
Net common stock issuance | --31.88K | --439.23K | 552.99%667.48K | ---- | --0 | ---- | --102.22K | ---- |
Net other financing activities | ---- | ---- | 36.18%-1.29K | ---- | ---- | ---- | ---2.02K | ---- |
Cash from discontinued financing activities | ||||||||
Financing cash flow | --31.88K | --439.23K | -56.05%664.69K | ---- | --0 | ---- | --1.51M | ---- |
Net cash flow | ||||||||
Beginning cash position | 52,051,579.89%403.96K | 2,179,460.97%17.46K | 15,591.94%42.84K | -7.70%0.7393 | --0.7761 | --0.801 | --273 | --0.801 |
Current changes in cash | ---94K | --58.44K | -161.97%-25.38K | ---- | ---- | ---- | --40.95K | ---- |
Effect of exchange rate changes | --2.23K | --0 | --0 | ---- | --0 | ---- | --1.61K | ---- |
End cash Position | 42,694,775.34%312.19K | 9,474,835.30%75.89K | -59.25%17.46K | -7.70%0.7393 | --0.7312 | --0.7761 | --42.84K | --0.801 |
Free cash from | ---52.31K | ---380.79K | 67.64%-690.07K | --0 | --0 | --0 | ---2.13M | --0 |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data